Hi ,

• How Geneticists are 'Base-ically' Revolutionizing Sickle-Cell Treatment. In a significant leap towards treating sickle cell disease and beta-thalassemia, researchers from St. Jude Children’s Research Hospital and the Broad Institute of MIT and Harvard harness a cutting-edge gene therapy approach, leveraging next-generation genome editing technology. 

• Sky-High Sustainability: SynBioBlox's Route to Cleaner Aviation Fuel. SynBioBlox is bringing to the table a unique approach hinging on synthetic biology, a method of engineering living cells to convert greenhouse gases into functional outputs like sustainable jet fuel.

• The Science of Smooth: Voodoo and Ginkgo's Gentle Spirits Revolution. In a quest to smooth out the sharp bite often associated with distilled spirits, Voodoo Scientific has teamed up with Ginkgo Bioworks to create a unique enzymatic solution. 

• UPSIDE Foods Makes History with First Consumer Sale of Cultivated Meat in the US and Highly Anticipated Restaurant Debut. Hosted by UPSIDE's CEO and Founder, Dr. Uma Valeti, and Chef Dominique Crenn, the inaugural group of consumers were selected from entrants to UPSIDE's social media contest based on their passion for building a better future. (Press release)

UPSIDE Foods' Cultivated Chicken Dish at Bar Crenn (PRNewsfoto/UPSIDE Foods)

• GANNI Fabrics of the Future showcases a blazer made of Celium, a leather alternative derived from bacterial cellulose. Polybion is growing premium, next-generation materials designed with nature and manufactured with biology. Their first product, Celium™, is a bacterial cellulose-based, high-performance leather substitute.

• LanzaTech Named to TIME’s List of the TIME100 Most Influential Companies: "We are extremely honored to be named as one of the TIME100 Most Influential Companies, alongside other audacious companies changing the world," said Jennifer Holmgren, CEO of LanzaTech. (Press release)

Other news:

• If you were at SynBioBeta this year, you would have seen several sessions on longevity and DeSci. If you're interested in these topics, check out the Longevity+DeSci Summit NYC by Lifespan.io, where leaders in longevity biotech and decentralized science meet to drive breakthroughs in aging science. Use code SYNBIO2023 for 10% off your ticket!

• Allbirds creates "world's first net-zero carbon shoe" using regenerative wool. Stuck to the front of the sneaker is a bioplastic smiley face badge by California company Mango Materials, which is made using captured methane emissions from a wastewater treatment facility that is then digested by bacteria and turned into a biopolyester called PHA. (Dezeen)

• Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines: The companies will provide researchers with an extensive collection of mammalian and mouse cell lines for gene editing applications, including Express Cell Pools, to increase speed to results. (Press release)

• The Netherlands Makes History as First European Country to Allow Cultivated Meat and Seafood Tastings. After this historic agreement, investors, partners, consumers, and scientists will soon taste Mosa Meat’s beef burgers, Meatable‘s cultivated pork, and future developments. (Vegconomist)

• ABPDU is organizing a virtual Expo focused on scale-up and biomanufacturing, specifically aiming to support our current and potential collaborators in scaling-up to commercial relevance. Sign up for ABPDU’s virtual Scale-Up Facilities Expo on August 7th from 6:00 A.M. – 2:00 P.M. Pacific Time.

• Liberation Labs Breaks Ground on its First Purpose-Built Precision Fermentation Biomanufacturing Facility: The new facility will produce bio-based proteins and other building-block ingredients at scale, offering a reliable, domestic, and cost-effective supply for a range of industries. (Press release)

• Ginkgo announces a partnership with Ambrosia Bio, an Israeli food tech company developing novel bioprocesses for the global sugar replacement industry. (Ginkgo Bioworks)syn

Regards,
Jeff

---

Jeff Buguliskis, PhD 

Director of Content, SynBioBeta

Who's hiring?

• Various Positions at Absci
  

• Various Positions at National Security Commission on Emerging Biotechnology
  

• Scientist - Bioprocessing at Macro Oceans (Sacramento, CA)

• Process Engineering Director at Macro Oceans (Sacramento, CA)

• Senior Government Team Coordinator at LanzaTech (Skokie, IL)

• Software Engineer at Latch Bio (San Francisco, CA)

• Summer 2023 Business Operations (Internship) at Latch Bio (San Francisco, CA)

• Bioprocess Lab Technician at Solugen (Houston, TX)

• Senior Scientist - Strain Engineering at Solugen (Houston, TX)

• Senior Scientist I – Protein Engineering at Solugen (Houston, TX)

• Scientist II – Heterogeneous Metals Catalysis at Solugen (Houston, TX)

• Sr. Compensation Analyst at Solugen (Houston, TX)

• Director/Senior Director, Quality & Compliance (GxP) at Bit.bio (Cambridge, UK)

• Director/Senior Director, Marketing (Research Products) at Bit.bio (Cambridge, UK)

• SVP, Pharma Business Development & Cell Therapy Partnerships at Bit.bio (Boston, MA)

• Scientist/Senior Scientist, Technical Operations at Bit.bio (Boston, MA)

• Scientist/Senior Scientist, Cell Type Development (Neuro) at (Cambridge, UK)

• Director- Laboratory Operations at Twist Bioscience (Quincy, MA)

• Senior Research Associate: Protein/Enzyme Engineering at Twist Bioscience (South San Francisco, CA)

• Account Manager, Antibody Discovery Services at Twist Bioscience (NY)

• Director – Molecular Biology and Antibody Engineering at Twist Bioscience (Quincy, MA)

• Director, SEC Reporting and Technical Accounting at Twist Bioscience (San Francisco, CA)

• Senior Scientist, RNA Therapeutics at Ginkgo Bioworks (Boston, MA)

• Senior Director, Gene Therapy at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - RNA at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - Pharma Enterprise Sales at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - Pharma Enterprise Sales at Ginkgo Bioworks (Boston, MA)

• Director, Business Development, Cell Engineering at Ginkgo Bioworks (Boston, MA)

• Senior Bioinformatics Engineer at Ginkgo Bioworks (Boston, MA)

• Associate Director, Lab Enablement at Ginkgo Bioworks (Boston, MA)

• Chief Strategy & Bioeconomic Development Officer at BioMADE (US)

• Multiple Positions with the National Security Commission on Emerging Biotechnology (NSCEB)

• Scientist II/Scientist III, Microbial Innovation Group at Inscripta (Pleasanton, CA)

• Senior/Staff Research Associate, Molecular Biology at Inscripta (Pleasanton, CA)

• Research Associate II/III, Analytical Chemistry at Inscripta (Pleasanton, CA)